Skinvive by Juvéderm, recently approved by the FDA, is an injectable gel designed to improve skin quality in the cheek area by increasing hydration. The announcement of this product’s approval makes Skinvive a first-of-its-kind product. According to a clinical study, Skinvive is safe and effective on all skin types and can improve skin health, hydration, and refreshedness while promoting a smoother, glowy appearance.
What is Skinvive?
Skinvive is a new, unique injectable hyaluronic acid gel. It is designed as an intradermal microdroplet injection, which means that tiny amounts of product are injected directly into the skin, rather than underneath the dermal layer. By injecting into the skin, the product is designed to promote hydration within the skin for a smoother, healthier, glowier appearance.
“SKINVIVE™ by JUVÉDERM® is a category-creating HA product that leaves skin looking healthier, more glowing, and more hydrated…This unique product is a result of our vast experience in HA science…”
– Carrie Strom, President of Allergan Aesthetics
Key points of Skinvive by Juvéderm:
- Improves skin quality in the cheeks by smoothing the skin and increasing hydration.
- Improves smoothness of the cheeks leading to a lasting glow.
- Specialized, smooth, hydrating gel that flows easily into the skin.
- FDA-approved for all Fitzpatrick Skin Types I-VI, lightest to darkest.
- Addresses an important unmet need in the skin quality category.
- Minimally invasive injectable treatment with little to no downtime.
- Provides results over the course of six months without requiring a recurring series of treatments.
Skinvive vs. Filler
While both Skinvive and traditional fillers are made of a hyaluronic acid gel, Skinvive is intended for an entirely different purpose. Unlike fillers, which are used to add volume and contour to various areas of the face, Skinvive is designed specifically to add hydration to the cheek area through small injections of this form of hyaluronic acid. The added hydration has been shown to improve overall skin quality and smoothness. This is something that most traditional fillers do not address.
In most cases, results of Skinvive can be seen within the first few weeks after treatment and can last for about 6-9 months without additional treatments.
In clinical trials, 91% of patients were more satisfied with their skin, 96% had smoother cheeks after treatment and after 6 months, patients still saw improvement after the initial treatment.
While 38% of study participants were happy with their facial skin healthiness before being treated, that number rose to 83% after treatment. Similarly, 24% of study participants were satisfied with their facial skin hydration before treatment, while 72% reported post-treatment satisfaction. Lastly, only 16% of participants were satisfied with their facial skin refreshedness before treatment, but 69% achieved satisfaction in this metric after treatment.
The cost of Skinvive treatments are currently not disclosed, as the product has not hit the US market yet. While it is up to the individual practice to set pricing, we can speculate that the product will be priced similarly to other Juvéderm injectable hyaluronic acid products. These products typically cost about $600-1,000 per syringe. It is not yet confirmed, but it is likely that Skinvive will require just one syringe per treatment, since it is an intradermal microdroplet injection for the cheek area only.
Skinvive Near Me
Skinvive is not yet available, but it is expected to launch by the end of 2023 in the US. In the meantime, we have many options for improving skin smoothness and glow. Call us at 877-750-0020 or text us at 201-425-0825 to schedule a complimentary consultation to learn what treatment is best for your needs and goals.